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EDITORIALHigh-Fat Diet, Dysbiosis, and Gastrointestinal and Colonic
Transit: Is There a Missing Link?n a series of elegant studies reported in this issue ofICellular and Molecular Gastroenterology and Hepatol-
ogy, Anitha et al1 report that a high-fat diet results in slowing
of gastrointestinal transit (by geometric center of ﬂuorescein
isothiocyanate distribution after gavage), total gastrointes-
tinal transit (by ﬁrst arrival of a blue dye in stool), and distal
colonic transit (by the time taken to expel a bead through the
last 2 cm of colon). This retardation of transit is associated
with increased numbers of fecal Firmicutes and reduced
numbers of Bacteroidetes. The high-fat diet also was associ-
ated with an increase in serum lipopolysaccharide, reﬂecting
increased permeability of the digestive tract, and reductions
in numbers of enteric nervous system neurons, with speciﬁc
loss of neurons expressing nitric oxide synthase. Anitha et al1
hypothesize that a reduction in nitric oxide synthase–
expressing neurons was the cause of retarded transit.
Oligofructose partly corrected transit rate, serum lipopoly-
saccharide, microbial perturbations, and a reduction in
enteric nervous system nitrergic neurons. Parallel in vitro
studies have suggested that dietary fat causes neuronal
apoptosis by activating Toll-like receptor 4.1
The data provided by the animal model lead to a number
of intriguing questions, some of which will require investi-
gation in human beings while others can be addressed
based on prior reports in the literature.
Is the Retardation of Transit the Result
of Obesity or the High-Fat Diet Per Se?
Both epidemiologic studies and actual measurements of
colonic transit in human beings suggest that a bodymass index
greater than 30 kg/m2 are associated with diarrhea rather
than constipation, and with faster colonic transit.2,3 Obesity
typically is associated with normal or accelerated gastric
emptying.4 This would suggest that the observed retardation
of transit is the result of the diet rather than the obesity per se.
However, in human studies, a high-fat diet was not associated
with retardation of colonic transit.5 The blue dye and ﬂuo-
rescein isothiocyanate method to evaluate overall gut and
small-intestinal transit in the study by Anitha et al1 started
with gastric gavage of themarker. Given the known retardation
of gastric emptying by high-fat loads6 and evidence of adap-
tation to the effects of fat,7 it would be interesting to further
evaluate the contributions of gastric transit to changes in
overall and distal colonic transit observed in the mouse model.
Does a High-Fat Diet Increase Intestinal
Permeability in Human Beings?
There is human evidence that a high-fat diet increases
serum lipopolysaccharide levels.8 Serum lipopolysaccharideCellulevels can be increased by direct diffusion owing to
increased intestinal paracellular permeability or by ab-
sorption across enterocytes during chylomicron secretion;
the precise mechanisms are being investigated actively.9
Consumption of a high-fat diet results in increased pro-
duction of bile, observed in both obese and lean animals.10
This was associated with reduced expression of claudin-1,
claudin-3, occludin, and junctional adhesion molecule-1 in
small, but not large, intestinal epithelial cells; consistent
with this, in vitro exposure of Caco-2 cell monolayers to bile
juice and fat emulsion increased tight junction permeability
and reduced tight junction protein expression.10
Are There Other Perturbations
Resulting From a High-Fat Diet That
May Result in the Observed Changes
in the Microbiome?
It is intriguing that the increase in Firmicutes and the
reduction in Bacteroidetes observed with a high-fat diet
have been reported with administration of the primary bile
acid cholic acid.11 Further studies are needed to better un-
derstand the mechanisms of this shift in microbial compo-
sition as well as its impact on metabolism and intestinal
function.
What is the Mechanism by Which
Oligofructose Corrects Fat-Induced
Functional Perturbations?
Oligofructose is a prebiotic fructan that, similar to inulin,
is not hydrolyzed or absorbed in the upper gastrointestinal
tract but undergoes variable degrees of fermentation in the
colon.12 The beneﬁcial effects are particularly interesting
given that diets low in fructans and other fermentable oligo-
di-monosaccharides and polyols are beneﬁcial in patients
with irritable bowel syndrome,13 although such diets are not
superior to traditionally recommended diets.14 Nonetheless,
it is clear that low fermentable oligo-di-monosaccharides and
polyols diets modify the gut microbiome,15 and that oligo-
saccharides increase fecal Biﬁdobacteria.16 Moreover, in
mice, oligofructose feeding increases the Bacteroidetes
abundance with a concomitant decrease in Firmicutes,17
similar to the changes observed by Anitha et al.1 Once
again, it is intriguing to note that dietary oligosaccharide
supplementation results in increased fecal bile acid levels in
rats, hamsters, and mice.18,19
Finally, Anitha et al1 focused on dysbiosis as a contrib-
utor to the effects of a high-fat diet. An alternative hypoth-
esis is that the effects are mediated at least in part by bilelar and Molecular Gastroenterology and Hepatology 2016;2:257–258
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acid) receptor with the bile acids chenodeoxycholic acid or
deoxycholic acid activated the main mitogen-activated pro-
tein kinases (extracellular signal–regulated kinase 1/2, p38,
and c-Jun-N-terminal kinase), as well as the nuclear factor-
kB signaling pathway in a monocyte cell line.20 Once again, it
is interesting to speculate that bile acids may be the missing
link.
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